
Myalink platform improves care for patients with myasthenia gravis
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000…
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000…
Researchers from the Berlin Institute of Health at Charité (BIH) and the Max Planck Institute for Molecular Genetics, in collaboration with…
With the support of SPARK-BIH and the BIH Biomedical Innovation Academy (BIA), the first cohorts in the project and personal funding programs of the…
Do you have an innovative idea or questions concerning IP and patents? The Idea Office is a service offered by Charité BIH Innovation, the joint…
BIH researchers and colleagues showed that public large-language models, such as DeepSeek, perform as well as proprietary models (e.g. GPT4o) that…
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH)…
Researchers from the Berlin Institute of Health at Charité (BIH), the Center for Musculoskeletal Surgery at Charité – Universitätsmedizin Berlin, Jena…
Researchers at the Berlin Institute of Health at Charité (BIH) and Charité - Universitätsmedizin Berlin have developed a customized single-cell…
Researchers from the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin have gained new insights into the…